Allergy/Imm Medical News about Multiple Sclerosis; Interferon-beta Theraphy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Interferon-beta Theraphy in Multiple Sclerosis Patients: is Response Age Dependent?
Journal of Neurological Sciences (Turkish), 06/22/09

Kurne A et al. - This study evaluates the two MS subgroups that are not in the range of expected age profiles (<20 and >40 years old patients). Although increasing evidence suggests a slower disease course in children with MS when compared to adults, significant disability can still accumulate by early adulthood. There are controversial reports regarding the prognosis of late onset MS patients...In this study, the response to IFN therapy in young onset MS patients has been found similar to older age onset MS patients.

<< Previous
Efficacy and safety of fixed-dose loratadine/montelukast in...

Next >>
Prefilament tau species as potential targets for immunotherapy...

Early Psychiatric Manifestation in a Patient with Primary Progressive Multiple Sclerosis
Archives of Iranian Medicine, 11/12/09 Relevance Score: 69%

Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09 Relevance Score: 69%

A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
Multiple Sclerosis, 10/01/09 Relevance Score: 69%

Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis
International Immunology, 10/14/09 Relevance Score: 68%

Early Drug Treatment May Cut Multiple Sclerosis Risk
MedLinePlus, 10/08/09 Relevance Score: 68%